NEOGENOMICS INC — Director's Dealing 2012

Dec 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2012-12-20

Reporting Person: HIPP RAYMOND R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-20	Common Stock	J	188571	$2.75	Acquired	235714	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24000	Direct

Footnotes

F1: This was acquired as part of a distribution of shares to certain limited partners of Aspen Select Healthcare, LP in conjunction with the final distribution of their limited partnership interests.

F2: On April 27, 2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Hipp remains a Director of the Company.